TrialNeuro-oncology2024

Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide.

Christina Maria Flies et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.